Clinical Trial Update: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating AMXI-5001 in patients with advanced cancers, including breast, ovarian, prostate, and pancreatic cancer, and the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• AMXI-5001 (AMXI-5001)

Snippet

Sponsor: AtlasMedx, Incorporated | Conditions: Advanced Malignant Neoplasm, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING